Nuclear Bodies and RNA Regulation in Psychiatric Disorders: Current Perspectives and Therapeutic Alternatives
Abstract
Nuclear bodies are membrane-less compartments formed via liquid-liquid phase separation (LLPS) and serve as "dynamic information-processing hubs" for key molecular processes, including transcription and RNA metabolism. In the nervous system, these functional condensates provide a physical substrate for the formation of diverse splicing isoforms, which are essential for maintaining the complexity of the human brain. Recent findings suggest that the collapse of this "nuclear infrastructure" is the underlying cause of several psychiatric disorders. This collapse is due to an aberrant phase transition, where the nuclear environment shifts from a reversible, dynamic state to an irreversible, rigid state-a disruption of the homeostatic mechanism known as "Interstasis." This review discusses how this physical transition leads to systemic splicing failure and explores next-generation therapeutic strategies, such as antisense oligonucleotides (ASOs) and small-molecule modifiers, to restore nuclear integrity. This review is structured as follows to systematically explore the nexus between subnuclear architecture and neuropsychiatric pathogenesis. Section 1 establishes the biophysical foundations of nuclear bodies, highlighting LLPS and homeostatic mechanisms like interstasis. Section 2 addresses the advanced diversity and spatiotemporal regulation of alternative splicing in the nervous system, with a particular focus on the neuron-specific long non-coding RNA Gomafu. Section 3 comprehensively dissects the molecular mechanisms of nuclear infrastructure collapse-encompassing aberrant phase transitions, microexon/novel exon dysregulation, and 3D genome and transport deficits-in neurodevelopmental disorders and schizophrenia. Finally, Section 4 outlines next-generation drug discovery strategies, focusing on therapeutic modalities such as ASOs and small molecules capable of modulating network-level analog states.
Related
- Microbiota Dysbiosis and the Gut-Brain Axis in Psychiatric Disorders: Molecular Mechanisms, Clinical Evidence, and Therapeutic Perspectives
- Panax ginseng in psychiatric disorders: Mechanisms and therapeutic potentials.
- Epigenetic regulation of immune checkpoint signaling by microbial metabolites: mechanisms, therapeutic potential, and future perspectives
- Natural Inhibitors of 5-Alpha Reductase: Mechanisms, Therapeutic Potential, and Emerging Perspectives in Androgen-Dependent Prostate Disorders
- Distinguishing different psychiatric disorders using DDx-PRS
BibTeX
@article{fukumitsu2026nuclear,
title = {{Nuclear Bodies and RNA Regulation in Psychiatric Disorders: Current Perspectives and Therapeutic Alternatives}},
author = {Hidefumi Fukumitsu and Hitomi Soumiya},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
month = sep,
doi = {10.1248/bpb.b26-00308},
url = {https://www.jstage.jst.go.jp/article/bpb/49/9/49_b26-00308/_article},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Nuclear Bodies and RNA Regulation in Psychiatric Disorders: Current Perspectives and Therapeutic Alternatives
AU - Hidefumi Fukumitsu
AU - Hitomi Soumiya
PY - 2026
DA - 2026/09/01
JO - Biological and Pharmaceutical Bulletin
DO - 10.1248/bpb.b26-00308
UR - https://www.jstage.jst.go.jp/article/bpb/49/9/49_b26-00308/_article
AB - Nuclear bodies are membrane-less compartments formed via liquid-liquid phase separation (LLPS) and serve as "dynamic information-processing hubs" for key molecular processes, including transcription and RNA metabolism. In the nervous system, these functional condensates provide a physical substrate for the formation of diverse splicing isoforms, which are essential for maintaining the complexity of the human brain. Recent findings suggest that the collapse of this "nuclear infrastructure" is the underlying cause of several psychiatric disorders. This collapse is due to an aberrant phase transition, where the nuclear environment shifts from a reversible, dynamic state to an irreversible, rigid state-a disruption of the homeostatic mechanism known as "Interstasis." This review discusses how this physical transition leads to systemic splicing failure and explores next-generation therapeutic strategies, such as antisense oligonucleotides (ASOs) and small-molecule modifiers, to restore nuclear integrity. This review is structured as follows to systematically explore the nexus between subnuclear architecture and neuropsychiatric pathogenesis. Section 1 establishes the biophysical foundations of nuclear bodies, highlighting LLPS and homeostatic mechanisms like interstasis. Section 2 addresses the advanced diversity and spatiotemporal regulation of alternative splicing in the nervous system, with a particular focus on the neuron-specific long non-coding RNA Gomafu. Section 3 comprehensively dissects the molecular mechanisms of nuclear infrastructure collapse-encompassing aberrant phase transitions, microexon/novel exon dysregulation, and 3D genome and transport deficits-in neurodevelopmental disorders and schizophrenia. Finally, Section 4 outlines next-generation drug discovery strategies, focusing on therapeutic modalities such as ASOs and small molecules capable of modulating network-level analog states.
SN - 1347-5215
SN - 0918-6158
ER -